Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.41 |
| ▸ | RARA | P10276 | 7/20 | 0.41 |
| ▸ | RARB | P10826 | 7/20 | 0.41 |
| ▸ | RARG | P13631 | 7/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 5/20 | 0.32 |
| ▸ | RXRB | P28702 | 3/20 | 0.32 |
| ▸ | RXRG | P48443 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9302684 | 0.89 | RARA (0.46) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL9302619 | 0.88 | CYP3A4 (0.39) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL9302949 | 0.85 | CYP3A4 (0.57) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL6664858 | 0.84 | CYP26A1 (0.46) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL6663854 | 0.82 | CYP26A1 (0.47) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL6664152 | 0.82 | CYP26A1 (0.45) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL9303655 | 0.82 | CYP3A4 (0.43) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL9302702 | 0.81 | RARA (0.41) | CYP3A4CYP26A1RARARARBRARG | |
| SCHEMBL9302749 | 0.81 | CYP26A1 (0.38) | CYP26A1RARARARBRARGRXRA | |
| SCHEMBL9302613 | 0.80 | CYP3A4 (0.39) | CYP3A4CYP26A1RARARARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5354752-A | A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis | ALLERGAN, INC. (US) | 1994-10-11 | — | — | US | claimed |